{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T06:33:27Z","timestamp":1648881207005},"reference-count":17,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Gynecology Obstetrics and Human Reproduction"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.jogoh.2019.06.004","type":"journal-article","created":{"date-parts":[[2019,6,15]],"date-time":"2019-06-15T10:40:05Z","timestamp":1560595205000},"page":"473-477","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinicopathologic characteristics of recurrent endometrioid endometrial cancer patients and analysis of methods used dur\u0131ing surveillance"],"prefix":"10.1016","volume":"48","author":[{"given":"S.Y.","family":"Simsek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Serbetcioglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Alemdaroglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Yetkinel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.D.","family":"Durdag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Celik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jogoh.2019.06.004_bib0005","unstructured":"Endometrial Cancer Incidence Rising Worldwide National Cancer Institute. https:\/\/www.cancer.gov\/news-events\/cancer-currents-blog\/2017\/endometrial-cancer-incidence-rising. Accessed April 14, 2018."},{"issue":"6","key":"10.1016\/j.jogoh.2019.06.004_bib0010","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/IGC.0b013e3181e2abcc","article-title":"Surveillance procedures for patients treated for endometrial cancer: a review of the literature","volume":"20","author":"Sartori","year":"2010","journal-title":"Int J Gynecol Cancer."},{"issue":"3","key":"10.1016\/j.jogoh.2019.06.004_bib0015","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ygyno.2006.02.011","article-title":"Follow-up after primary therapy for endometrial cancer: A systematic review","volume":"101","author":"Fung-Kee-Fung","year":"2006","journal-title":"Gynecol Oncol."},{"key":"10.1016\/j.jogoh.2019.06.004_bib0020","series-title":"NCCN Guidelines Version 1.2018 Panel Members Uterine Neoplasms Continue NCCN Guidelines Panel Disclosures Emily Wyse Patient Advocate MD\/Liaison Dana-Farber\/Brigham and Women\u2019s Cancer Center","author":"Nicole McMillian","year":"2018"},{"issue":"2","key":"10.1016\/j.jogoh.2019.06.004_bib0025","first-page":"413","article-title":"ACOG practice bulletin, clinical management guidelines for obstetrician-gynecologists, number 65, August 2005: management of endometrial cancer","volume":"106","author":"American College of Obstetricians and Gynecologists","year":"2005","journal-title":"Obstet Gynecol"},{"issue":"Oct (6)","key":"10.1016\/j.jogoh.2019.06.004_bib0030","article-title":"Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"24","author":"Colombo","year":"2013","journal-title":"Ann Oncol."},{"key":"10.1016\/j.jogoh.2019.06.004_bib0035","first-page":"2977","article-title":"Adherence to guidelines during follow-up of Endometrial Cancer : Analysis of French Health Insurance Database","volume":"38","author":"Phelippeau","year":"2018","journal-title":"Anticancer Res."},{"key":"10.1016\/j.jogoh.2019.06.004_bib0040","unstructured":"Fact Sheets by Population. http:\/\/globocan.iarc.fr\/Pages\/fact_sheets_population.aspx. Accessed June 17, 2018."},{"issue":"6","key":"10.1016\/j.jogoh.2019.06.004_bib0045","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ajog.2011.03.008","article-title":"Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations","volume":"204","author":"Salani","year":"2011","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.jogoh.2019.06.004_bib0050","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1136\/ijgc-00009577-200409000-00029","article-title":"The clinical value and the cost- effectiveness of follow-up in endometrial cancer patients","volume":"14","author":"Tjalma","year":"2004","journal-title":"Int J Gynecol Cancer"},{"issue":"3B","key":"10.1016\/j.jogoh.2019.06.004_bib0055","first-page":"1977","article-title":"An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer","volume":"20","author":"Gadducci","year":"2000","journal-title":"Anticancer Res."},{"issue":"8","key":"10.1016\/j.jogoh.2019.06.004_bib0060","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0959-8049(01)00066-1","article-title":"Value and cost evaluation of routine follow-up for patients with clinical stage I\/II endometrial cancer","volume":"37","author":"Morice","year":"2001","journal-title":"Eur J Cancer."},{"issue":"1","key":"10.1016\/j.jogoh.2019.06.004_bib0065","first-page":"12","article-title":"Serial serum CA 125 measurements for evaluation of recurrence in patients with endometrial carcinoma","volume":"84","author":"Rose","year":"1994","journal-title":"Obstet Gynecol."},{"issue":"2","key":"10.1016\/j.jogoh.2019.06.004_bib0070","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0002-9378(90)90400-2","article-title":"Use of serum CA 125 measurement in posttreatment surveillance of early-stage endometrial carcinoma","volume":"162","author":"Patsner","year":"1990","journal-title":"Am J Obstet Gynecol."},{"issue":"7","key":"10.1016\/j.jogoh.2019.06.004_bib0075","first-page":"879","article-title":"Costs and benefits of routine follow-up after curative treatment for endometrial cancer","volume":"157","author":"Agboola","year":"1997","journal-title":"CMAJ"},{"issue":"1","key":"10.1016\/j.jogoh.2019.06.004_bib0080","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/1471-0528.14000","article-title":"Comparing hospital and telephone follow-up for patients treated for stage-I endometrial cancer (ENDCAT trial): a randomised, multicentre, non-inferiority trial","volume":"124","author":"Beaver","year":"2017","journal-title":"BJOG An Int J Obstet Gynaecol."},{"issue":"7","key":"10.1016\/j.jogoh.2019.06.004_bib0085","doi-asserted-by":"crossref","first-page":"e002859","DOI":"10.1136\/bmjopen-2013-002859","article-title":"Gynaecological cancer follow-up: national survey of current practice in the UK","volume":"3","author":"Leeson","year":"2013","journal-title":"BMJ Open."}],"container-title":["Journal of Gynecology Obstetrics and Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468784719301953?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468784719301953?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T12:35:30Z","timestamp":1567168530000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468784719301953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":17,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S2468784719301953"],"URL":"https:\/\/doi.org\/10.1016\/j.jogoh.2019.06.004","relation":{},"ISSN":["2468-7847"],"issn-type":[{"value":"2468-7847","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinicopathologic characteristics of recurrent endometrioid endometrial cancer patients and analysis of methods used dur\u0131ing surveillance","name":"articletitle","label":"Article Title"},{"value":"Journal of Gynecology Obstetrics and Human Reproduction","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jogoh.2019.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}